Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1289 (LINC01289) is a human gene that produces a long intergenic non-coding RNA (lincRNA). LincRNAs, such as LINC01289, are RNA transcripts longer than 200 nucleotides that do not overlap protein-coding genes and do not encode proteins themselves[1][3][5]. Instead, they participate in the regulation of gene expression, frequently through mechanisms such as chromatin remodeling, transcriptional regulation, or serving as scaffolds for protein complexes. While many lincRNAs have been implicated in various biological processes including cancer, the specific biological functions and disease associations of LINC01289 remain largely uncharacterized in current publicly available sources[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1289 (LINC01289).